Harmonised human biomonitoring in Europe: Activities towards an EU HBM framework

被引:62
|
作者
Joas, Reinhard [1 ]
Casteleyn, Ludwine [2 ]
Biot, Pierre [3 ]
Kolossa-Gehring, Marike [4 ]
Castano, Argelia [5 ]
Angerer, Juergen [6 ]
Schoeters, Greet [7 ]
Sepai, Ovnair [8 ]
Knudsen, Lisbeth E. [9 ]
Joas, Anke [1 ]
Horvat, Milena [10 ]
Bloemen, Louis
机构
[1] BiPRO GmbH, Res Inst Integrated Solut, D-81545 Munich, Germany
[2] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[3] FPS Hlth Food Chain Safety & Environm, B-1060 Brussels, Belgium
[4] Fed Environm Agcy, D-14195 Berlin, Germany
[5] Inst Salud Carlos III, Majadahonda 28220, Spain
[6] Ruhr Univ Bochum, Inst Prevent & Occupat Med IPA, D-44789 Bochum, Germany
[7] Flemish Inst Technol Res VITO, B-2400 Mol, Belgium
[8] Ctr Radiat Chem & Environm Hazards CRCE, Hlth Protect Agcy, London 0X11 0RQ, England
[9] Univ Copenhagen, Dept Publ Hlth, DK-1353 Copenhagen, Denmark
[10] Jozef Stefan Inst, Ljubljana, Slovenia
关键词
Monitoring; Biomarker; Environment and health; Policy tool; Protocol; Pollutants;
D O I
10.1016/j.ijheh.2011.08.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Human biomonitoring (HBM) can be an effective tool to assess human exposure to environmental pollutants and potential health effects and is increasingly seen as an essential element in a strategy when integrating health and environment. HBM can be used (i) to prioritise actions and measures for policy making; (ii) to evaluate policy actions aimed at reducing exposure to potentially hazardous environmental stressors; and (iii) to promote more comprehensive health impact assessments of policy options. In support of the European Environment and Health Action Plan 2004-2010, European scientists, experts from authorities and other stakeholders joined forces to work towards developing a functional framework and standards for a coherent HBM in Europe. Within the European coordination action on human biomonitoring, 35 partners from 27 European countries in the COPHES consortium aggregated their experiences and expertise and developed harmonized approaches and recommendations for better comparability of HBM data in Europe via the elaboration of a harmonized study protocol. This protocol is the product of discussion and compromises on the selection of environmental exposures, national environmental health concerns, and political and health priorities. The harmonised approach includes sampling recruitment, and analytical procedures, communication strategies and biobanking initiatives. The protocols and the harmonised approach are a means to increase acceptance and policy support and to in the future to enable determination of time trends. The common pilot study protocol will shortly be tested, adapted and assessed in the framework of the DEMOCOPHES in 17 European countries, including 16 EU Member States. COPHES and DEMOCOPHES constitute important steps towards establishing human biomonitoring as a tool for EU environmental and health policy and to improve quantification of exposure of the general European population to existing and emerging pollutants. (C) 2011 Published by Elsevier GmbH.
引用
收藏
页码:172 / 175
页数:4
相关论文
共 50 条
  • [1] Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative
    Weise, Philipp
    Apel, Petra
    Kolossa-Gehring, Marike
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2022, 65 (09) : 936 - 939
  • [2] Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A
    Ougier, Eva
    Zeman, Florence
    Antignac, Jean-Philippe
    Rousselle, Christophe
    Lange, Rosa
    Kolossa-Gehring, Marike
    Apel, Petra
    [J]. ENVIRONMENT INTERNATIONAL, 2021, 154
  • [3] Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants
    Gilles, Liese
    Govarts, Eva
    Martin, Laura Rodriguez
    Andersson, Anna-Maria
    Appenzeller, Brice M. R.
    Barbone, Fabio
    Castano, Argelia
    Coertjens, Dries
    Den Hond, Elly
    Dzhedzheia, Vazha
    ErZen, Ivan
    Lopez, Marta Esteban
    Fabelova, Lucia
    Fillol, Clemence
    Franken, Carmen
    Frederiksen, Hanne
    Gabriel, Catherine
    Haug, Line Smastuen
    Horvat, Milena
    Halldorsson, Thorhallur Ingi
    Janasik, Beata
    Holcer, NataSa Janev
    Kakucs, Reka
    Karakitsios, Spyros
    Katsonouri, Andromachi
    Klanova, Jana
    Kold-Jensen, Tina
    Kolossa-Gehring, Marike
    Konstantinou, Corina
    Koponen, Jani
    Lignell, Sanna
    Lindroos, Anna Karin
    Makris, Konstantinos C.
    Mazej, Darja
    Morrens, Bert
    Murinova, Lubica PalkoviCova
    Namorado, Sonia
    Pedraza-Diaz, Susana
    Peisker, Jasmin
    Probst-Hensch, Nicole
    Rambaud, Loic
    Rosolen, Valentina
    Rucic, Enrico
    Ruether, Maria
    Sarigiannis, Dimosthenis
    Tratnik, Janja Snoj
    Standaert, Arnout
    Stewart, Lorraine
    Szigeti, Tamas
    Thomsen, Cathrine
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (11)
  • [4] Recent Steps to a Harmonised Approach to HBM Across Europe
    Casteleyn, Ludwine
    Van Tongelen, Birgit
    Joas, Reinhard
    Polcher, Alexandra
    Biot, Pierre
    Viso, Anne Catherine
    [J]. EPIDEMIOLOGY, 2009, 20 (06) : S261 - S262
  • [5] Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for cadmium and its compounds
    Lamkarkach, Farida
    Ougier, Eva
    Garnier, Robert
    Viau, Claude
    Kolossa-Gehring, Marike
    Lange, Rosa
    Apel, Petra
    [J]. ENVIRONMENT INTERNATIONAL, 2021, 147
  • [6] Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide
    Lamkarkach, Farida
    Meslin, Matthieu
    Kolossa-Gehring, Marike
    Apel, Petra
    Garnier, Robert
    [J]. TOXICS, 2022, 10 (06)
  • [7] Human-Biomonitoring für Europa (HBM4EU) – erste Einblicke in die Ergebnisse der InitiativeHuman Biomonitoring for Europe (HBM4EU)—first insights into the results of the initiative
    Philipp Weise
    Petra Apel
    Marike Kolossa-Gehring
    [J]. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2022, 65 (9) : 936 - 939
  • [8] Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment
    Apel, Petra
    Rousselle, Christophe
    Lange, Rosa
    Sissoko, Fatoumata
    Kolossa-Gehring, Marike
    Ougier, Eva
    [J]. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2020, 230
  • [9] Key results of the european human biomonitoring initiative-HBM4EU
    Kolossa-Gehring, Marike
    Schoeters, Greet
    Castan, Argelia
    Barouki, Robert
    Haines, Douglas
    Polcher, Alexandra
    Weise, Philipp
    [J]. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2023, 253
  • [10] Human Biomonitoring Guidance Values for Deoxynivalenol Derived under the European Human Biomonitoring Initiative (HBM4EU)
    Mengelers, Marcel J. B.
    van den Brand, Annick D.
    Zhao, Shensheng
    Hoogenveen, Rudolf
    Ougier, Eva
    [J]. TOXINS, 2024, 16 (03)